Scientists at the Task Force for Global Health recently presented an assessment of what must be done to achieve the World Health Organization (WHO) goal of eliminating hepatitis B and C virus infections as public health threats by 2030 and to prevent more than 7 million related deaths.
The report was authored by John Ward, MD, a Senior Scientist at the US Centers for Disease Control and Prevention (CDC) assigned to the task force, and Alan Hinman, MD, a Consulting Advisor for the Center for Vaccine Equity (CVE) program at the task force. The Task Force for Global Health is a nongovernmental organization based in Decatur, Georgia, with field offices in Addis Ababa, Ethiopia, and Islamabad, Pakistan.
The WHO goal targets a 90% reduction of 2015 levels in new chronic infections, to fewer than 1 million new infections per year and a 65% reduction in deaths to fewer than 500,000 deaths per year.
Causes of death in England among persons with the diagnosis of HCV were determined through record linkage. Linking persons ≥1yrs with anti-HCV/HCV-PCR tests reported to PHE sentinel surveillance during 2002-2016 to death registrations from the Office for National Statistics during 2008-2016, researchers identified death of 8.6% of the 204,265 with evidence of HCV. The leading underlying causes of death were external causes (accidental poisoning from drugs) and liver disease (end stage liver disease, liver cancer, hepatitis, alcohol and non-alcohol related); 18% and 34.5%, respectively. Persons with evidence of HCV had a lower median age of death than the general population (53 years vs 81 years). New HCV treatments have led to a relative reduction in liver–related deaths in 2016 compared to 2015. This study supports that for monitoring all-cause mortality among those with HCV and quantifying underreporting of HCV in death registrations, data linkage between laboratory diagnosis and deaths data is an important tool.
The story of The Chills and its frontman Martin Phillipps is almost ready for release, after premiering at the American film festival SWXS.
Local fans will have to wait until May to see The Chills: The Triumph & Tragedy of Martin Phillipps, a documentary which examines the startling highs and monstrous lows of Phillipps and his Dunedin rock band.
On Monday, the film’s maker released a trailer for the documentary. It also confirmed the film would be in cinemas on May 2, for New Zealand Music Month. A special screening was planned for the night before, in Dunedin.
LOS ANGELES (FOX 11) – Los Angeles County health officials said six cases of hepatitis C have been linked to a Mid-City medical clinic, and hundreds of patients who were treated at the facility are being urged to get tested.
According to the county Department of Public Health, the agency has sent letters to about 500 people who were treated at Westside Multispecialty Medical Group, 6200 Wilshire Blvd., providing information about hepatitis C and the availability of free testing.
The clinic operators have agreed to close down while an investigation into the outbreak continues, according to the county.
There’s a proposal in Tallahassee right now that could make it easier for injection drug users to trade dirty needles for fresh ones — preventing the spread of HIV and Hepatitis C.
A trial project in Miami Dade County is the only legal needle exchange in Florida. The bill would let the other counties to create something similar.
There’s a spot along 11th street in Overtown in Miami that’s surrounded by a convergence of overpasses. And this time last year, a guy with heavy black arrows tattooed on his arms showed up there pretty regularly.
DURHAM — A federal judge has ordered North Carolina prisons to expand testing and treatment for hepatitis C, which kills more American than any other infectious disease.
The injunction follows a class-action lawsuit filed by three inmates who say thousands of incarcerated people in North Carolina are going undiagnosed due to a lack of universal hepatitis C testing. Hundreds with the liver infection are developing health complications while the state denies them potentially life-saving medication, the lawsuit states.
U.S. District Judge William Osteen Jr. issued a ruling Wednesday that calls for the N.C. Department of Public Safety to screen all inmates for hepatitis C, unless they opt out. The state’s current policy only calls for testing people with risk factors.
On the threshold of obtaining results from a clinical trial of a newly developed vaccine against hepatitis C virus (HCV) in a population at-risk for infection, investigators have described the challenges they have encountered and the prospects for success.
“A potential new vaccine to prevent HCV infection has been tested in Baltimore and at two other sites in the US, and the results of that trial will be available by summer,” Andrea Cox, MD, PhD, Professor of Medicine and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, told MD Magazine®.
“We are hopeful that this vaccine will be able to protect against HCV and stem the rising tide of HCV infections in the US,” she said.